Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas by Nastos, K, Cheung, V, Toumpanakis, C, Navalkissoor, S, Quigley, A, Caplin, M, Khoo, B

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues by Wolin EM, Jarzab B, Eriksson B, Walter T, Toumpanakis C, Morse MA, Tomassetti P, Weber MM, Fogelman DR, Ramage J, Poon D, Gadbaw B, Li J, Pasieka JL, Mahamat A, Swahn F, Newell-Price J, Mansoor W, Öberg K

Get full text

A comprehensive characterization of chronic norovirus infection in immunodeficient hosts by Brown, L-AK, Ruis, C, Clark, I, Roy, S, Brown, JR, Albuquerque, AS, Patel, SY, Miller, J, Karim, MY, Dervisevic, S, Moore, J, Williams, CA, Cudini, J, Moreira, F, Neild, P, Seneviratne, SL, Workman, S, Toumpanakis, C, Atkinson, C, Burns, SO, Breuer, J, Lowe, DM